| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +4.90% | +0.87% | +4.03% | +3.06% | — |
| 14d | 4 | +50.00% | +0.44% | +0.91% | -0.46% | +1.15% | — |
| 30d | 4 | +50.00% | +2.84% | +1.19% | +1.66% | +1.15% | — |
| 60d | 4 | +25.00% | +13.58% | +4.89% | +8.69% | +10.19% | — |
| 90d | 4 | +25.00% | +22.69% | +4.20% | +17.60% | +13.99% | — |
| 180d | 4(1 pending) | +0.00% | +45.56% | +9.78% | +49.75% | +49.75% | — |
| 1y | 4(3 pending) | +0.00% | +180.80% | +27.31% | +153.49% | +153.49% | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TXG 10X GENOMICS, INC. | SALE Chief Financial Officer | 15,098 | $24.44 | $369.0K | 379,898 | May 22, 2026 | May 27, 2026 ↗ | View → |
| TXG 10X GENOMICS, INC. | PURCHASEGRANT Stock grant | 106,579 | — | — | 394,996 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| TXG 10X GENOMICS, INC. | SALE Chief Financial Officer | 8,968 | $18.58 | $166.6K | 288,417 | Feb 23, 2026 | Feb 25, 2026 ↗ | View → |
| TXG 10X GENOMICS, INC. | SALE Chief Financial Officer | 11,888 | $19.00 | $225.9K | 297,385 | Nov 24, 2025 | Nov 25, 2025 ↗ | View → |
| TXG 10X GENOMICS, INC. | SALE Chief Financial Officer | 22,315 | $13.79 | $307.7K | 309,273 | Aug 22, 2025 | Aug 26, 2025 ↗ | View → |
| TXG 10X GENOMICS, INC. | SALE Chief Financial Officer | 4,044 | $8.30 | $33.6K | 331,588 | May 22, 2025 | May 27, 2025 ↗ | View → |
| TXG 10X GENOMICS, INC. | PURCHASEGRANT Stock grant | 133,928 | — | — | 335,632 | Mar 17, 2025 | Mar 19, 2025 ↗ | View → |
| TXG 10X GENOMICS, INC. | PURCHASEGRANT Stock grant | 201,704 | — | — | 201,704 | Oct 23, 2024 | Mar 19, 2025 ↗ | View → |